<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37333294</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>Post-acute immunological and behavioral sequelae in mice after Omicron infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2023.06.05.543758</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2023.06.05.543758</ELocationID><Abstract><AbstractText>Progress in understanding long COVID and developing effective therapeutics is hampered in part by the lack of suitable animal models. Here we used ACE2-transgenic mice recovered from Omicron (BA.1) infection to test for pulmonary and behavioral post-acute sequelae. Through in-depth phenotyping by CyTOF, we demonstrate that na&#xef;ve mice experiencing a first Omicron infection exhibit profound immune perturbations in the lung after resolving acute infection. This is not observed if mice were first vaccinated with spike-encoding mRNA. The protective effects of vaccination against post-acute sequelae were associated with a highly polyfunctional SARS-CoV-2-specific T cell response that was recalled upon BA.1 breakthrough infection but not seen with BA.1 infection alone. Without vaccination, the chemokine receptor CXCR4 was uniquely upregulated on multiple pulmonary immune subsets in the BA.1 convalescent mice, a process previously connected to severe COVID-19. Taking advantage of recent developments in machine learning and computer vision, we demonstrate that BA.1 convalescent mice exhibited spontaneous behavioral changes, emotional alterations, and cognitive-related deficits in context habituation. Collectively, our data identify immunological and behavioral post-acute sequelae after Omicron infection and uncover a protective effect of vaccination against post-acute pulmonary immune perturbations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Tongcui</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Gladstone Institutes of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of California, San Francisco, San Francisco, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suryawanshi</LastName><ForeName>Rahul K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Gladstone Institutes of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Stephanie R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ly</LastName><ForeName>Katie K</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Reuben</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elphick</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Kailin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Gladstone Institutes of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of California, San Francisco, San Francisco, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Gladstone Institutes of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of California, San Francisco, San Francisco, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaliss</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Irene P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>Gladstone Institutes of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Sciences Graduate Program, University of California San Francisco; San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of California San Francisco; San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Core Facility Functional Peptidomics, Ulm University Medical Center, Meyerhofstrasse 1, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montano</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gladstone Institutes of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sreekumar</LastName><ForeName>Bharath</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Gladstone Institutes of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Standker</LastName><ForeName>Ludger</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Core Facility Functional Peptidomics, Ulm University Medical Center, Meyerhofstrasse 1, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;nch</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Core Facility Functional Peptidomics, Ulm University Medical Center, Meyerhofstrasse 1, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heath Damron</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Cell Biology, West Virginia University School of Medicine, Morgantown WV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palop</LastName><ForeName>Jorge J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ott</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gladstone Institutes of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of California San Francisco; San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chan Zuckerberg Biohub, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roan</LastName><ForeName>Nadia R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Gladstone Institutes of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of California, San Francisco, San Francisco, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 DK063720</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 AI164671</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG073082</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD018040</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062629</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG062234</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo><CoiStatement>COMPETING FINANCIAL INTERESTS The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>2</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37333294</ArticleId><ArticleId IdType="pmc">PMC10274741</ArticleId><ArticleId IdType="doi">10.1101/2023.06.05.543758</ArticleId><ArticleId IdType="pii">2023.06.05.543758</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis H. E., McCorkell L., Vogel J. M. &amp; Topol E. J. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21, 133&#x2013;146, doi:10.1038/s41579-022-00846-2 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J. et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv, doi:10.1101/2022.08.09.22278592 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881&#x2013;895 e820, doi:10.1016/j.cell.2022.01.014 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K. et al. Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. bioRxiv, doi:10.1101/2023.02.09.527892 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.02.09.527892</ArticleId><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon I. S. et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol 6, eabk1741, doi:10.1126/sciimmunol.abk1741 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abk1741</ArticleId><ArticleId IdType="pmc">PMC8763087</ArticleId><ArticleId IdType="pubmed">34591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S. R. et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758&#x2013;763, doi:10.1038/s41586-022-05542-y (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey T. M. et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107&#x2013;113, doi:10.1038/s41586-021-03570-8 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryawanshi R. K. et al. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature 607, 351&#x2013;355, doi:10.1038/s41586-022-04865-0 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04865-0</ArticleId><ArticleId IdType="pmc">PMC9279157</ArticleId><ArticleId IdType="pubmed">35584773</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019, doi:10.1016/j.eclinm.2021.101019 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M. J. et al. Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement. Open Forum Infect Dis 9, ofab640, doi:10.1093/ofid/ofab640 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab640</ArticleId><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L. et al. Innate immune cell activation causes lung fibrosis in a humanized model of long COVID. Proc Natl Acad Sci U S A 120, e2217199120, doi:10.1073/pnas.2217199120 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2217199120</ArticleId><ArticleId IdType="pmc">PMC10013740</ArticleId><ArticleId IdType="pubmed">36848564</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A. et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 185, 2452-+, doi:10.1016/j.cell.2022.06.008 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I. et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun 13, 1745, doi:10.1038/s41467-022-29440-z (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnon K. H. 3rd et al. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice. Sci Transl Med 14, eabo5070, doi:10.1126/scitranslmed.abo5070 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abo5070</ArticleId><ArticleId IdType="pmc">PMC9273046</ArticleId><ArticleId IdType="pubmed">35857635</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontes-Dantas F. L. et al. SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep 42, 112189, doi:10.1016/j.celrep.2023.112189 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112189</ArticleId><ArticleId IdType="pmc">PMC9935273</ArticleId><ArticleId IdType="pubmed">36857178</ArticleId></ArticleIdList></Reference><Reference><Citation>Luxem K. et al. Identifying behavioral structure from deep variational embeddings of animal motion. Commun Biol 5, 1267, doi:10.1038/s42003-022-04080-7 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-04080-7</ArticleId><ArticleId IdType="pmc">PMC9674640</ArticleId><ArticleId IdType="pubmed">36400882</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassert M. et al. mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2. PLoS Pathog 16, e1009163, doi:10.1371/journal.ppat.1009163 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009163</ArticleId><ArticleId IdType="pmc">PMC7773324</ArticleId><ArticleId IdType="pubmed">33326500</ArticleId></ArticleIdList></Reference><Reference><Citation>Roederer M., Nozzi J. L. &amp; Nason M. C. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79, 167&#x2013;174, doi:10.1002/cyto.a.21015 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.21015</ArticleId><ArticleId IdType="pmc">PMC3072288</ArticleId><ArticleId IdType="pubmed">21265010</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y. et al. CXCR5(+)PD-1(+) follicular helper CD8 T cells control B cell tolerance. Nat Commun 10, 4415, doi:10.1038/s41467-019-12446-5 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12446-5</ArticleId><ArticleId IdType="pmc">PMC6765049</ArticleId><ArticleId IdType="pubmed">31562329</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman L. Random forests. Mach Learn 45, 5&#x2013;32, doi:Doi 10.1023/A:1010933404324 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1010933404324</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M. et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis 22, 43&#x2013;55, doi:10.1016/S1473-3099(21)00460-6 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D. et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ 377, e069676, doi:10.1136/bmj-2021-069676 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Neidleman J. et al. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19. Cell Rep 36, 109414, doi:10.1016/j.celrep.2021.109414 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109414</ArticleId><ArticleId IdType="pmc">PMC8238659</ArticleId><ArticleId IdType="pubmed">34260965</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis A. et al. DeepLabCut: markerless pose estimation of user-defined body parts with deep learning. Nat Neurosci 21, 1281&#x2013;1289, doi:10.1038/s41593-018-0209-y (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0209-y</ArticleId><ArticleId IdType="pubmed">30127430</ArticleId></ArticleIdList></Reference><Reference><Citation>Eddins D. J. et al. Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load. Blood Adv 7, 778&#x2013;799, doi:10.1182/bloodadvances.2022008834 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2022008834</ArticleId><ArticleId IdType="pmc">PMC9906672</ArticleId><ArticleId IdType="pubmed">36399523</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter M. A. et al. HIV-Specific CD8(+) T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid Tissue. Cell Rep 21, 3458&#x2013;3470, doi:10.1016/j.celrep.2017.11.075 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.11.075</ArticleId><ArticleId IdType="pmc">PMC5764192</ArticleId><ArticleId IdType="pubmed">29262326</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi P., Huang M. &amp; Zhu H. Exploring potential biomarkers and therapeutic targets of long COVID-associated inflammatory cardiomyopathy. Front Med (Lausanne) 10, 1191354, doi:10.3389/fmed.2023.1191354 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1191354</ArticleId><ArticleId IdType="pmc">PMC10346863</ArticleId><ArticleId IdType="pubmed">37457560</ArticleId></ArticleIdList></Reference><Reference><Citation>Cane S., Ponnappan S. &amp; Ponnappan U. Altered regulation of CXCR4 expression during aging contributes to increased CXCL12-dependent chemotactic migration of CD4(+) T cells. Aging Cell 11, 651&#x2013;658, doi:10.1111/j.1474-9726.2012.00830.x (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2012.00830.x</ArticleId><ArticleId IdType="pmc">PMC3399962</ArticleId><ArticleId IdType="pubmed">22568557</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms M. et al. An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation. Acta Pharm Sin B 11, 2694&#x2013;2708, doi:10.1016/j.apsb.2020.12.005 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC8463264</ArticleId><ArticleId IdType="pubmed">34589390</ArticleId></ArticleIdList></Reference><Reference><Citation>Muri J. et al. Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course. Nat Immunol 24, 604&#x2013;611, doi:10.1038/s41590-023-01445-w (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01445-w</ArticleId><ArticleId IdType="pmc">PMC10063443</ArticleId><ArticleId IdType="pubmed">36879067</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. People who catch Omicron are less likely to get Long Covid.</Citation></Reference><Reference><Citation>Fernandez-Castaneda A. et al. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv, doi:10.1101/2022.01.07.475453 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588, doi:10.1038/s41586-020-2700-3 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Flemming A. Comparing neurological complications after COVID-19 vaccination and SARS-CoV-2 infection. Nat Rev Immunol 21, 761, doi:10.1038/s41577-021-00655-3 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00655-3</ArticleId><ArticleId IdType="pmc">PMC8569501</ArticleId><ArticleId IdType="pubmed">34741166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T. et al. Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIV. Elife 11, doi:10.7554/eLife.78870 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.78870</ArticleId><ArticleId IdType="pmc">PMC9255966</ArticleId><ArticleId IdType="pubmed">35787792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T. C. et al. HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread. Elife 9, e55487. doi: 10.7554/eLife.55487 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.55487</ArticleId><ArticleId IdType="pmc">PMC7250576</ArticleId><ArticleId IdType="pubmed">32452381</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuyler R. P. et al. Minimizing Batch Effects in Mass Cytometry Data. Front Immunol 10, 2367, doi:10.3389/fimmu.2019.02367 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02367</ArticleId><ArticleId IdType="pmc">PMC6803429</ArticleId><ArticleId IdType="pubmed">31681275</ArticleId></ArticleIdList></Reference><Reference><Citation>Villanueva R. A. M. &amp; Chen Z. J. ggplot2: Elegant Graphics for Data Analysis, 2nd edition. Meas-Interdiscip Res 17, 160&#x2013;167, doi:10.1080/15366367.2019.1565254 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15366367.2019.1565254</ArticleId></ArticleIdList></Reference><Reference><Citation>George A. F. et al. Deep Phenotypic Analysis of Blood and Lymphoid T and NK Cells From HIV+ Controllers and ART-Suppressed Individuals. Front Immunol 13, 803417, doi:10.3389/fimmu.2022.803417 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.803417</ArticleId><ArticleId IdType="pmc">PMC8829545</ArticleId><ArticleId IdType="pubmed">35154118</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates D., Machler M., Bolker B. M. &amp; Walker S. C. Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw 67, 1&#x2013;48, doi:DOI 10.18637/jss.v067.i01 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v067.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>A K. rstatix: Pipe-Friendly Framework for Basic Statistical Tests_. R package version 0.7.2, &lt;https://CRAN.R-project.org/package=rstatix&gt; (2023).</Citation></Reference><Reference><Citation>C D. ggprism: A &#x2018;ggplot2&#x2019; Extension Inspired by &#x2018;GraphPad Prism&#x2019;_. R package version 1.0.4. (2022).</Citation></Reference><Reference><Citation>Favuzzi E. et al. GABA-receptive microglia selectively sculpt developing inhibitory circuits. Cell 184, 5686, doi:10.1016/j.cell.2021.10.009 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.009</ArticleId><ArticleId IdType="pmc">PMC9122269</ArticleId><ArticleId IdType="pubmed">34715023</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>